CIDRAP newsletters options
The guidance offers a peek of what life might be when we move beyond COVID-19.
US in-hospital mortality for COVID-19 was almost 14% overall but decreased 15 percentage points from March to August 2020, with higher rates in older patients, according to a research letter published in JAMA Network Open late last week.
The WHO and its partners will assess shortages of raw materials like plastic, glass, stoppers, and vials.
Only 5 of 789 (0.6%) had inflammatory heart disease and were restricted from play.
CDC Director Walensky says an average of 60,000 new cases per day and 2,000 deaths is still too high.
GAO emphasizes addressing the backlog, pre-announced inspections, and alternative approaches.
Among US children and teens hospitalized with COVID-19 or its related multisystem inflammatory syndrome in children (MIS-C), 22% had neurologic conditions, most of them transient but 12% of them life-threatening or fatal, according to a study today in JAMA Neurology.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Treatment with azithromycin had little effect on reducing the time to recovery or risk of hospitalization in patients with suspected COVID-19, according to a randomized clinical trial published yesterday in The Lancet.
One more Ebola case has been reported from Nzerekore, where the country's latest outbreak has been under way since the middle of February, Ibrahima Soce Fall, MD, assistant director-general for emergency response at the World Health Organization (WHO), said today at a briefing.
States are grappling with how best to distribute vaccines to the most vulnerable residents as fast as possible.
Cases are surging in central and eastern Europe, as well as in the west, where new illness numbers are already high.
Early administration of the antiparasitic drug didn't shorten time to clinical improvement.
A study today in the journal Family Practice reports that a rapid, multi-viral point-of-care test for respiratory infections was easy to use, acceptable to patients and clinicians, and appeared to influence clinical reasoning about antibiotics.
A modeling study published yesterday in Science projects increased transmissibility of the B117 strain of COVID-19, also known as the UK strain, and warns that the strain could likely cause a resurgence of high virus activity in the United Kingdom and make 2021 a deadlier year than 2020.
It's striking that mental healthcare increased significantly at the same time that overall medical care fell.
Cases are leveling off just as the rate of the B117 variant climbs—a bad sign.
In the northern Amazon basin where cases are spiking, ICUs in Brazil, Peru, and Colombia are filling up with COVID-19 patients.
Two studies yesterday in Infection Control & Hospital Epidemiology provide a snapshot of dental antibiotic prescribing among Veterans Affairs (VA) dental patients.
The P1 variant that caused a second wave of COVID-19 infections in Manaus, Brazil, is more transmissible and from 25% to 61% of previously infected people may be susceptible to reinfection, according to a preprint, non–peer-reviewed study from researchers at the University of Sao Paulo, Imperial College London, and the University of Oxford.
Low-resource nations have borne the brunt of shaky oxygen supply chains, even before COVID.
